Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise

被引：397

作者：

Dannenberg, AJ ^{[1
]}

Subbaramaiah, K

机构：

[1] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA

[2] Strang Canc Prevent Ctr, New York, NY 10021 USA

来源：

CANCER CELL | 2003年 / 4卷 / 06期

关键词：

D O I：

10.1016/S1535-6108(03)00310-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：431 / 436

页数：6

共 38 条

[1] Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer [J].

Altorki, NK ;

Keresztes, RS ;

Port, JL ;

Libby, MD ;

Korst, RJ ;

Flieder, DB ;

Ferrara, CA ;

Yankelevitz, DF ;

Subbaramaiah, K ;

Pasmantier, MW ;

Dannenberg, AJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2645-2650

[2] Host prostaglandin E2-EP3 signaling regulates tumor-associated angiogenesis and tumor growth [J].

Amano, H ;

Hayashi, J ;

Endo, H ;

Kitasato, H ;

Yamashina, S ;

Maruyama, T ;

Kobayashi, M ;

Satoh, K ;

Narita, M ;

Sugimoto, Y ;

Murata, T ;

Yoshimura, H ;

Narumiya, S ;

Majima, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) :221-232

[3]

Araki Y, 2003, CANCER RES, V63, P728

[4] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[5] Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor [J].

Buchanan, FG ;

Wang, DZ ;

Bargiacchi, F ;

DuBois, RN .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :35451-35457

[6] Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer: preliminary report [J].

Chow, LWC ;

Wong, JLN ;

Toi, M .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5) :443-447

[7] Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: A rational advance? [J].

Choy, H ;

Milas, L .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19) :1440-1452

[8]

Chulada PC, 2000, CANCER RES, V60, P4705

[9]

Daniel TO, 1999, CANCER RES, V59, P4574

[10] Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer [J].

Dannenberg, AJ ;

Altorki, NK ;

Boyle, JO ;

Dang, C ;

Howe, LR ;

Weksler, BB ;

Subbararnaiah, K .

LANCET ONCOLOGY, 2001, 2 (09) :544-551

← 1 2 3 4 →